245 related articles for article (PubMed ID: 29615501)
1. CRISPR/Cas9-Mediated Gene Disruption Reveals the Importance of Zinc Metabolism for Fitness of the Dimorphic Fungal Pathogen Blastomyces dermatitidis.
Kujoth GC; Sullivan TD; Merkhofer R; Lee TJ; Wang H; Brandhorst T; Wüthrich M; Klein BS
mBio; 2018 Apr; 9(2):. PubMed ID: 29615501
[No Abstract] [Full Text] [Related]
2. Gene Editing in Dimorphic Fungi Using CRISPR/Cas9.
Kujoth GC; Sullivan TD; Klein BS
Curr Protoc Microbiol; 2020 Dec; 59(1):e132. PubMed ID: 33315302
[TBL] [Abstract][Full Text] [Related]
3. Two Distinct Approaches for CRISPR-Cas9-Mediated Gene Editing in Cryptococcus neoformans and Related Species.
Wang P
mSphere; 2018 Jun; 3(3):. PubMed ID: 29898980
[No Abstract] [Full Text] [Related]
4. Postnatal Cardiac Gene Editing Using CRISPR/Cas9 With AAV9-Mediated Delivery of Short Guide RNAs Results in Mosaic Gene Disruption.
Johansen AK; Molenaar B; Versteeg D; Leitoguinho AR; Demkes C; Spanjaard B; de Ruiter H; Akbari Moqadam F; Kooijman L; Zentilin L; Giacca M; van Rooij E
Circ Res; 2017 Oct; 121(10):1168-1181. PubMed ID: 28851809
[TBL] [Abstract][Full Text] [Related]
5. CRISPR-Cas9-Mediated Gene Silencing in Cultured Human Epithelia.
Gago S; Overton NLD; Bowyer P
Methods Mol Biol; 2021; 2260():37-47. PubMed ID: 33405030
[TBL] [Abstract][Full Text] [Related]
6. Design of a generic CRISPR-Cas9 approach using the same sgRNA to perform gene editing at distinct loci.
Najah S; Saulnier C; Pernodet JL; Bury-Moné S
BMC Biotechnol; 2019 Mar; 19(1):18. PubMed ID: 30894153
[TBL] [Abstract][Full Text] [Related]
7. TEAD4 regulates trophectoderm differentiation upstream of CDX2 in a GATA3-independent manner in the human preimplantation embryo.
Stamatiadis P; Cosemans G; Boel A; Menten B; De Sutter P; Stoop D; Chuva de Sousa Lopes SM; Lluis F; Coucke P; Heindryckx B
Hum Reprod; 2022 Jul; 37(8):1760-1773. PubMed ID: 35700449
[TBL] [Abstract][Full Text] [Related]
8. CRISPR-Cas9 in genome editing: Its function and medical applications.
Khadempar S; Familghadakchi S; Motlagh RA; Farahani N; Dashtiahangar M; Rezaei H; Gheibi Hayat SM
J Cell Physiol; 2019 May; 234(5):5751-5761. PubMed ID: 30362544
[TBL] [Abstract][Full Text] [Related]
9. Introduction of Large Sequence Inserts by CRISPR-Cas9 To Create Pathogenicity Mutants in the Multinucleate Filamentous Pathogen Sclerotinia sclerotiorum.
Li J; Zhang Y; Zhang Y; Yu PL; Pan H; Rollins JA
mBio; 2018 Jun; 9(3):. PubMed ID: 29946044
[TBL] [Abstract][Full Text] [Related]
10. Development of a CRISPR/Cas9 System for Methylococcus capsulatus
Tapscott T; Guarnieri MT; Henard CA
Appl Environ Microbiol; 2019 Jun; 85(11):. PubMed ID: 30926729
[TBL] [Abstract][Full Text] [Related]
11. Efficient Editing of the Nuclear
Guzmán-Zapata D; Sandoval-Vargas JM; Macedo-Osorio KS; Salgado-Manjarrez E; Castrejón-Flores JL; Oliver-Salvador MDC; Durán-Figueroa NV; Nogué F; Badillo-Corona JA
Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30871076
[TBL] [Abstract][Full Text] [Related]
12. RNA-dependent RNA targeting by CRISPR-Cas9.
Strutt SC; Torrez RM; Kaya E; Negrete OA; Doudna JA
Elife; 2018 Jan; 7():. PubMed ID: 29303478
[TBL] [Abstract][Full Text] [Related]
13. CRISPR/Cas9 gene-editing strategies in cardiovascular cells.
Vermersch E; Jouve C; Hulot JS
Cardiovasc Res; 2020 Apr; 116(5):894-907. PubMed ID: 31584620
[TBL] [Abstract][Full Text] [Related]
14. Targeted gene disruption reveals an adhesin indispensable for pathogenicity of Blastomyces dermatitidis.
Brandhorst TT; Wüthrich M; Warner T; Klein B
J Exp Med; 1999 Apr; 189(8):1207-16. PubMed ID: 10209038
[TBL] [Abstract][Full Text] [Related]
15. An Era of CRISPR/ Cas9 Mediated Plant Genome Editing.
Khurshid H; Jan SA; Shinwari ZK; Jamal M; Shah SH
Curr Issues Mol Biol; 2018; 26():47-54. PubMed ID: 28879855
[TBL] [Abstract][Full Text] [Related]
16. Two CRISPR/Cas9 Systems Developed in Thermomyces dupontii and Characterization of Key Gene Functions in Thermolide Biosynthesis and Fungal Adaptation.
Huang WP; Du YJ; Yang Y; He JN; Lei Q; Yang XY; Zhang KQ; Niu XM
Appl Environ Microbiol; 2020 Oct; 86(20):. PubMed ID: 32769197
[No Abstract] [Full Text] [Related]
17. Turning on virulence: Mechanisms that underpin the morphologic transition and pathogenicity of
McBride JA; Gauthier GM; Klein BS
Virulence; 2019 Dec; 10(1):801-809. PubMed ID: 29532714
[TBL] [Abstract][Full Text] [Related]
18. Application of CRISPR-Cas9-Mediated Genome Editing for the Treatment of Myotonic Dystrophy Type 1.
Marsh S; Hanson B; Wood MJA; Varela MA; Roberts TC
Mol Ther; 2020 Dec; 28(12):2527-2539. PubMed ID: 33171139
[TBL] [Abstract][Full Text] [Related]
19. Comparative analysis of mouse and human preimplantation development following POU5F1 CRISPR/Cas9 targeting reveals interspecies differences.
Stamatiadis P; Boel A; Cosemans G; Popovic M; Bekaert B; Guggilla R; Tang M; De Sutter P; Van Nieuwerburgh F; Menten B; Stoop D; Chuva de Sousa Lopes SM; Coucke P; Heindryckx B
Hum Reprod; 2021 Apr; 36(5):1242-1252. PubMed ID: 33609360
[TBL] [Abstract][Full Text] [Related]
20. Ribozyme-mediated, multiplex CRISPR gene editing and CRISPR interference (CRISPRi) in rodent-infectious
Walker MP; Lindner SE
J Biol Chem; 2019 Jun; 294(24):9555-9566. PubMed ID: 31043479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]